Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer
Clinical trial NCT00039052 · COMPLETED
Trial details
- NCT number
- NCT00039052
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-01-01
- Primary completion
- 2003-05-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.